ONCTERNAL THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.4 USD | +1.33% |
|
-1.75% | -21.67% |
Chart calendar Oncternal Therapeutics, Inc.
e2d01b0.JvP0bTm4Q93ndtnPR6jo3wH_zW9ls4Qwpm1Lv8rhCFA.a6uGWg_LEbiBBLGFIPentnaRly4uxeYCkz8F7obXfDJRtqc7fN85rZZCtg~8a52de211de427dba789c726d07f687c
Upcoming events on Oncternal Therapeutics, Inc.
Past events on Oncternal Therapeutics, Inc.
| 19/03/2024 15:00 | Investor Meeting - Key Opinion Leader |
| 07/03/2024 22:00 | Q4 2023 Earnings Call |
| 07/03/2024 21:01 | Q4 2023 Earnings Release |
| 13/02/2024 21:40 | Oppenheimer Healthcare Life Sciences Conference |
| 07/01/2024 | Reverse Split: 1 of 20 |
| 09/11/2023 22:00 | Q3 2023 Earnings Call |
| 09/11/2023 21:01 | Q3 2023 Earnings Release |
| 18/09/2023 | Northland Capital Markets Institutional Investor Conference |
| 11/09/2023 | H.C. Wainwright Global Investment Conference |
| 10/08/2023 22:00 | Q2 2023 Earnings Call |
| 10/08/2023 21:01 | Q2 2023 Earnings Release |
| 28/06/2023 16:00 | Annual General Meeting |
| 07/06/2023 21:30 | Jefferies Global Healthcare Conference |
| 04/05/2023 22:00 | Q1 2023 Earnings Call |
| 04/05/2023 21:01 | Q1 2023 Earnings Release |
| 18/04/2023 18:30 | Investor Meeting - Oppenheimer & Co |
| 03/04/2023 22:00 | Business Update Call |
| 14/03/2023 19:20 | Oppenheimer Healthcare Conference |
| 09/03/2023 22:00 | Q4 2022 Earnings Call |
| 09/03/2023 21:01 | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,38 2,37 42.2% | 4,32 4,82 -10.4% | 1,49 1,60 -6.9% | 0,79 0,63 24.9% | 0,54 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -17,5 -20,0 12.15% | -31,4 -35,6 11.82% | -44,9 -45,3 0.82% | -41,7 -41,7 0.08% | -39,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -31,3 -35,4 11.39% | -44,2 -44,7 1.24% | -39,5 -39,3 -0.42% | -37,2 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -31,3 -35,4 11.39% | -44,2 -44,9 1.71% | -39,5 -39,5 0.08% | -37,8 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -12,8 -14,4 11.11% | -16,8 -16,8 0.2% | -13,4 -13,4 -0.26% | -10,7 |
| Announcement Date | 11/03/21 | 10/03/22 | 09/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,56 1,06 -47.39% | 0,75 0,53 42.1% | 0,19 0,46 -58.39% | 0,38 0,25 49.9% | 0,17 0,28 -39.82% | 0,20 0,14 42.1% | 0,11 0,17 -37.95% | 0,18 0,13 43.2% | 0,30 0,14 116% | 0,13 | 0,13 | 0,13 | 0,14 |
|
EBIT Million USD | Released Forecast Spread | -8,08 -12,3 34.22% | -9,91 -9,99 0.76% | -11,8 -11,4 -3.11% | -11,3 -12,6 10.16% | -11,9 -12,3 3.07% | -12,1 -11,9 -2.23% | -9,55 -10,1 5.56% | -10,4 -9,09 -14.25% | -9,64 -9,67 0.33% | -9,53 | -9,53 | -9,81 | -10,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,07 -12,1 33.28% | -9,90 -12,4 20.1% | -11,7 -11,5 -2.18% | -11,1 -12,2 8.58% | -11,4 -11,9 4.58% | -11,5 -11,1 -3.29% | -8,97 -8,98 0.1% | -9,86 -8,24 -19.64% | -9,16 -9,00 -1.84% | -9,06 | -8,96 | -9,19 | -10,0 |
|
Net income Million USD | Released Forecast Spread | -8,07 -12,1 33.28% | -9,90 -11,9 17.08% | -11,7 -12,4 5.13% | -11,1 -13,1 15.08% | -11,4 -12,2 6.27% | -11,5 -11,7 1.97% | -8,97 -9,81 8.59% | -9,86 -8,74 -12.85% | -9,16 -9,20 0.38% | -9,08 | -9,11 | -9,41 | -10,2 |
|
EPS USD | Released Forecast Spread | -3,40 -4,80 29.17% | -4,00 -4,80 16.67% | -4,60 -5,00 8% | -4,20 -4,90 14.29% | -4,00 -4,20 4.76% | -4,00 -3,97 -0.72% | -3,00 -3,33 10% | -3,40 -2,90 -17.24% | -3,11 -3,09 -0.81% | -2,88 | -2,61 | -2,62 | -2,70 |
| Announcement Date | 10/03/22 | 05/05/22 | 09/08/22 | 03/11/22 | 09/03/23 | 04/05/23 | 10/08/23 | 09/11/23 | 07/03/24 | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Oncternal Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ONCT Stock
- Calendar Oncternal Therapeutics, Inc.
